442 related articles for article (PubMed ID: 29464943)
1. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
[TBL] [Abstract][Full Text] [Related]
2. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
3. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
4. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
7. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
[TBL] [Abstract][Full Text] [Related]
8. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
9. Efficient Isolation and Phenotypic Profiling of Circulating Hepatocellular Carcinoma Cells via a Combinatorial-Antibody-Functionalized Microfluidic Synergetic-Chip.
Zhu L; Lin H; Wan S; Chen X; Wu L; Zhu Z; Song Y; Hu B; Yang C
Anal Chem; 2020 Nov; 92(22):15229-15235. PubMed ID: 33124804
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
11. A micro-/nano-chip and quantum dots-based 3D cytosensor for quantitative analysis of circulating tumor cells.
Wu X; Xiao T; Luo Z; He R; Cao Y; Guo Z; Zhang W; Chen Y
J Nanobiotechnology; 2018 Sep; 16(1):65. PubMed ID: 30205821
[TBL] [Abstract][Full Text] [Related]
12. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
[TBL] [Abstract][Full Text] [Related]
13. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
14. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
15. A microfluidic device for differential capture of heterogeneous rare tumor cells with epithelial and mesenchymal phenotypes.
Wang X; Deng L; Gjertsen BT
Anal Chim Acta; 2020 Sep; 1129():1-11. PubMed ID: 32891378
[TBL] [Abstract][Full Text] [Related]
16. Enrichment and mutation detection of circulating tumor cells from blood samples.
Kou R; Zhao J; Gogoi P; Carskadon S; Chow W; Hwang C; Palanisamy N; Leung C; Wang Y
Oncol Rep; 2018 Jun; 39(6):2537-2544. PubMed ID: 29620284
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.
Green BJ; Nguyen V; Atenafu E; Weeber P; Duong BTV; Thiagalingam P; Labib M; Mohamadi RM; Hansen AR; Joshua AM; Kelley SO
Anal Chem; 2019 Aug; 91(15):9348-9355. PubMed ID: 31264404
[TBL] [Abstract][Full Text] [Related]
18. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
19. 3D printed microfluidic devices for circulating tumor cells (CTCs) isolation.
Chen J; Liu CY; Wang X; Sweet E; Liu N; Gong X; Lin L
Biosens Bioelectron; 2020 Feb; 150():111900. PubMed ID: 31767348
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
